{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:23:46Z","timestamp":1790936626700,"version":"4.1.0"},"reference-count":50,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"4596","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Science"],"published-print":{"date-parts":[[1983,4,29]]},"abstract":"<jats:p>\n            A syndrome of spontaneous orofacial dyskinesia was identified in groups of rats treated for 6 months with a wide range of neuroleptic drugs. Phenothiazines, thioxanthenes, and substituted benzamides were particularly likely to induce the syndrome. It was observed in the presence of a functional blockade of dopamine receptors and endured for at least 2.5 months after drug withdrawal. There was no relation between the syndrome and changes in striatal dopamine receptors, as indexed by the binding of tritiated spiperone and tritiated\n            <jats:italic>cis<\/jats:italic>\n            (Z)-flupenthixol. The syndrome parallels several of the features of clinical tardive dyskinesia, whose pathophysiology thus may not involve changes in the characteristics of striatal dopamine receptors.\n          <\/jats:p>","DOI":"10.1126\/science.6132447","type":"journal-article","created":{"date-parts":[[2006,10,5]],"date-time":"2006-10-05T18:37:18Z","timestamp":1160073438000},"page":"530-532","source":"Crossref","is-referenced-by-count":165,"title":["Spontaneous Orofacial Dyskinesia and Dopaminergic Function in Rats After 6 Months of Neuroleptic Treatment"],"prefix":"10.1126","volume":"220","author":[{"given":"John L.","family":"Waddington","sequence":"first","affiliation":[{"name":"Division of Psychiatry, M.R.C. Clinical Research Centre, Northwick Park Hospital, Harrow, Middlesex HA1 3UJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Cross","sequence":"additional","affiliation":[{"name":"Division of Psychiatry, M.R.C. Clinical Research Centre, Northwick Park Hospital, Harrow, Middlesex HA1 3UJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Gamble","sequence":"additional","affiliation":[{"name":"Division of Psychiatry, M.R.C. Clinical Research Centre, Northwick Park Hospital, Harrow, Middlesex HA1 3UJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel C.","family":"Bourne","sequence":"additional","affiliation":[{"name":"Division of Psychiatry, M.R.C. Clinical Research Centre, Northwick Park Hospital, Harrow, Middlesex HA1 3UJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_2_1_1_1","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1176\/ajp.137.10.1163","volume":"137","year":"1980","unstructured":"AMERICAN JOURNAL OF PSYCHIATRY 137: 1163 (1980).","journal-title":"AMERICAN JOURNAL OF PSYCHIATRY"},{"key":"e_1_2_1_2_1","first-page":"459","volume":"33","year":"1972","unstructured":"AYD, F.J., HALOPERIDOL - 15 YEARS OF CLINICAL EXPERIENCE, DISEASES OF THE NERVOUS SYSTEM 33: 459 (1972).","journal-title":"DISEASES OF THE NERVOUS SYSTEM"},{"key":"e_1_2_1_3_1","first-page":"807","volume":"39","year":"1978","unstructured":"AYD, F.J., HALOPERIDOL - 20 YEARS CLINICAL EXPERIENCE, JOURNAL OF CLINICAL PSYCHIATRY 39: 807 (1978).","journal-title":"JOURNAL OF CLINICAL PSYCHIATRY"},{"key":"e_1_2_1_4_1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1017\/S0317167100025221","volume":"4","year":"1977","unstructured":"BEDARD, P, CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES 4: 197 (1977).","journal-title":"CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES"},{"key":"e_1_2_1_5_1","first-page":"232P","article-title":"Influence of 6 Month Treatments with metoclopramide, Piflutixol and Haloperidol on Behabior and Striatal (3H)-spiperone Binding","volume":"76","year":"1982","unstructured":"BOURNE, R.C., Influence of 6 Month Treatments with metoclopramide, Piflutixol and Haloperidol on Behabior and Striatal (3H)-spiperone Binding, BRITISH JOURNAL OF PHARMACOLOGY 76 1: 232P (1982).","journal-title":"BRITISH JOURNAL OF PHARMACOLOGY"},{"key":"e_1_2_1_6_1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF00426727","volume":"61","year":"1979","unstructured":"BOWERS, M.B., TARDIVE-DYSKINESIA - CLINICAL-TEST OF THE SUPER-SENSITIVITY HYPOTHESIS, PSYCHOPHARMACOLOGY 61: 137 (1979).","journal-title":"PSYCHOPHARMACOLOGY"},{"key":"e_1_2_1_7_1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1192\/bjp.118.543.171","volume":"118","year":"1971","unstructured":"BRANDON, S, STUDY OF FACIAL DYSKINESIA IN A MENTAL HOSPITAL POPULATION, BRITISH JOURNAL OF PSYCHIATRY 118: 171 (1971).","journal-title":"BRITISH JOURNAL OF PSYCHIATRY"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.847477"},{"key":"e_1_2_1_9_1","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1176\/ajp.138.10.1362","volume":"138","year":"1981","unstructured":"CERNANSKY, J.G., AMERICAN JOURNAL OF PSYCHIATRY 138: 1362 (1981).","journal-title":"AMERICAN JOURNAL OF PSYCHIATRY"},{"key":"e_1_2_1_10_1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1176\/ajp.136.1.79","volume":"136","year":"1979","unstructured":"CHOUINARD, G, FACTORS RELATED TO TARDIVE-DYSKINESIA, AMERICAN JOURNAL OF PSYCHIATRY 136: 79 (1979).","journal-title":"AMERICAN JOURNAL OF PSYCHIATRY"},{"key":"e_1_2_1_11_1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-2999(80)90438-0","volume":"63","year":"1980","unstructured":"CLOW, A, CEREBRAL DOPAMINE FUNCTION IN RATS FOLLOWING WITHDRAWAL FROM ONE YEAR OF CONTINUOUS NEUROLEPTIC ADMINISTRATION, EUROPEAN JOURNAL OF PHARMACOLOGY 63: 145 (1980).","journal-title":"EUROPEAN JOURNAL OF PHARMACOLOGY"},{"key":"e_1_2_1_12_1","first-page":"3","volume":"3","year":"1967","unstructured":"CRANE, G. E., INTERNATIONAL JOURNAL OF NEUROPSYCHIATRY 3 1: 3 (1967).","journal-title":"INTERNATIONAL JOURNAL OF NEUROPSYCHIATRY"},{"key":"e_1_2_1_13_1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0014-2999(81)90035-2","volume":"71","year":"1981","unstructured":"CROSS, A.J., KAINIC ACID LESIONS DISSOCIATE [H-3] SPIPERONE AND [H-3] CIS-FLUPENTHIXOL BINDING-SITES IN RAT STRIATUM, EUROPEAN JOURNAL OF PHARMACOLOGY 71: 327 (1981).","journal-title":"EUROPEAN JOURNAL OF PHARMACOLOGY"},{"key":"e_1_2_1_14_1","first-page":"860","year":"1981","unstructured":"CROW, T.J., BIOL PSYCHIAT: 860 (1981).","journal-title":"BIOL PSYCHIAT"},{"key":"e_1_2_1_15_1","first-page":"336","volume":"2","year":"1982","unstructured":"CROW, T.J., ABNORMAL INVOLUNTARY MOVEMENTS IN SCHIZOPHRENIA - ARE THEY RELATED TO THE DISEASE PROCESS OR ITS TREATMENT - ARE THEY ASSOCIATED WITH CHANGES IN DOPAMINE-RECEPTORS, JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY 2: 336 (1982).","journal-title":"JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY"},{"key":"e_1_2_1_16_1","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/archpsyc.1976.01770070088010","volume":"33","year":"1976","unstructured":"DAVIS, J.M., COMPARATIVE DOSES AND COSTS OF ANTIPSYCHOTIC MEDICATION, ARCHIVES OF GENERAL PSYCHIATRY 33: 858 (1976).","journal-title":"ARCHIVES OF GENERAL PSYCHIATRY"},{"key":"e_1_2_1_17_1","first-page":"16","volume":"42","year":"1981","unstructured":"EZRINWATERS, C, TARDIVE-DYSKINESIA IN SCHIZOPHRENIC OUTPATIENTS - PREVALENCE AND SIGNIFICANT VARIABLES, JOURNAL OF CLINICAL PSYCHIATRY 42: 16 (1981).","journal-title":"JOURNAL OF CLINICAL PSYCHIATRY"},{"key":"e_1_2_1_18_1","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1192\/bjp.135.6.500","volume":"135","year":"1979","unstructured":"FAMUYIWA, O.O., TARDIVE-DYSKINESIA AND DEMENTIA, BRITISH JOURNAL OF PSYCHIATRY 135: 500 (1979).","journal-title":"BRITISH JOURNAL OF PSYCHIATRY"},{"key":"e_1_2_1_19_1","first-page":"240P","article-title":"Six months phenothiazine treatment differentially influences distinct dopamine-mediated behaviours","volume":"73","year":"1981","unstructured":"GAMBLE, S. J., Six months phenothiazine treatment differentially influences distinct dopamine-mediated behaviours, BRITISH JOURNAL OF PHARMACOLOGY 73: 240P (1981).","journal-title":"BRITISH JOURNAL OF PHARMACOLOGY"},{"key":"e_1_2_1_20_1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0364-7722(77)90037-6","volume":"1","year":"1977","unstructured":"GARDOS, G, DRUG VARIABLES IN ETIOLOGY OF TARDIVE-DYSKINESIA APPLICATION OF DISCRIMINANT FUNCTION ANALYSIS, PROGRESS IN NEURO-PSYCHOPHARMACOLOGY 1: 147 (1977).","journal-title":"PROGRESS IN NEURO-PSYCHOPHARMACOLOGY"},{"key":"e_1_2_1_21_1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF00426838","volume":"50","year":"1976","unstructured":"GUNNE, L.M., HALOPERIDOL-INDUCED TARDIVE-DYSKINESIA IN MONKEYS, PSYCHOPHARMACOLOGY 50: 237 (1976).","journal-title":"PSYCHOPHARMACOLOGY"},{"key":"e_1_2_1_22_1","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1176\/ajp.131.8.910","volume":"131","year":"1974","unstructured":"JACOBSON, G, TARDIVE AND WITHDRAWAL DYSKINESIA ASSOCIATED WITH HALOPERIDOL, AMERICAN JOURNAL OF PSYCHIATRY 131: 910 (1974).","journal-title":"AMERICAN JOURNAL OF PSYCHIATRY"},{"key":"e_1_2_1_23_1","first-page":"297","volume":"138","year":"1981","unstructured":"JESTE, D.V., CHANGING EPIDEMIOLOGY OF TARDIVE-DYSKINESIA - AN OVERVIEW, AMERICAN JOURNAL OF PSYCHIATRY 138: 297 (1981).","journal-title":"AMERICAN JOURNAL OF PSYCHIATRY"},{"key":"e_1_2_1_24_1","first-page":"455","volume":"42","year":"1981","unstructured":"JESTE, D.V., DOGMA DISPUTED - IS TARDIVE-DYSKINESIA DUE TO POSTSYNAPTIC DOPAMINE RECEPTOR SUPER-SENSITIVITY, JOURNAL OF CLINICAL PSYCHIATRY 42: 455 (1981).","journal-title":"JOURNAL OF CLINICAL PSYCHIATRY"},{"key":"e_1_2_1_25_1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/archpsyc.1982.04290040069010","volume":"39","year":"1982","unstructured":"KANE, J.M., TARDIVE-DYSKINESIA - PREVALENCE AND RISK-FACTORS, 1959 TO 1979, ARCHIVES OF GENERAL PSYCHIATRY 39: 473 (1982).","journal-title":"ARCHIVES OF GENERAL PSYCHIATRY"},{"key":"e_1_2_1_26_1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00431929","volume":"77","year":"1982","unstructured":"KANE, J.M., PREVALENCE OF ABNORMAL INVOLUNTARY MOVEMENTS (SPONTANEOUS DYSKINESIAS) IN THE NORMAL ELDERLY, PSYCHOPHARMACOLOGY 77: 105 (1982).","journal-title":"PSYCHOPHARMACOLOGY"},{"key":"e_1_2_1_27_1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/277093a0","volume":"277","year":"1979","unstructured":"KEBABIAN, J.W., MULTIPLE RECEPTORS FOR DOPAMINE, NATURE 277: 93 (1979).","journal-title":"NATURE"},{"key":"e_1_2_1_28_1","first-page":"900","volume":"138","year":"1981","unstructured":"KLAWANS, H.L., AMERICAN JOURNAL OF PSYCHIATRY 138: 900 (1981).","journal-title":"AMERICAN JOURNAL OF PSYCHIATRY"},{"key":"e_1_2_1_29_1","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1212\/WNL.32.5.558","volume":"32","year":"1982","unstructured":"KLAWANS, H.L., PREVALENCE OF SPONTANEOUS LINGUAL-FACIAL-BUCCAL DYSKINESIAS IN THE ELDERLY, NEUROLOGY 32: 558 (1982).","journal-title":"NEUROLOGY"},{"key":"e_1_2_1_30_1","first-page":"305","volume":"2","year":"1982","unstructured":"KOVACIC, B, A MONKEY MODEL OF TARDIVE-DYSKINESIA (TD) - EVIDENCE THAT REVERSIBLE TD MAY TURN INTO IRREVERSIBLE TD, JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY 2: 305 (1982).","journal-title":"JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY"},{"key":"e_1_2_1_31_1","first-page":"113","volume":"34","year":"1973","unstructured":"MAN, P.L., LONG-TERM EFFECTS OF HALOPERIDOL, DISEASES OF THE NERVOUS SYSTEM 34: 113 (1973).","journal-title":"DISEASES OF THE NERVOUS SYSTEM"},{"key":"e_1_2_1_32_1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00433805","volume":"72","year":"1980","unstructured":"MCKINNEY, W.T., LONG-TERM CHLORPROMAZINE IN RHESUS-MONKEYS - PRODUCTION OF DYSKINESIAS AND CHANGES IN SOCIAL-BEHAVIOR, PSYCHOPHARMACOLOGY 72: 35 (1980).","journal-title":"PSYCHOPHARMACOLOGY"},{"key":"e_1_2_1_33_1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-510X(74)90104-X","volume":"21","year":"1974","unstructured":"MESSIHA, F.S., STUDY OF BIOGENIC-AMINE METABOLITES IN CEREBROSPINAL-FLUID AND URINE OF MONKEYS WITH CHLORPROMAZINE-INDUCED DYSKINESIA, JOURNAL OF THE NEUROLOGICAL SCIENCES 21: 39 (1974).","journal-title":"JOURNAL OF THE NEUROLOGICAL SCIENCES"},{"key":"e_1_2_1_34_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00429171","volume":"60","year":"1978","unstructured":"MULLER, P, DOPAMINERGIC SUPER-SENSITIVITY AFTER NEUROLEPTICS - TIME-COURSE AND SPECIFICITY, PSYCHOPHARMACOLOGY 60: 1 (1978).","journal-title":"PSYCHOPHARMACOLOGY"},{"key":"e_1_2_1_35_1","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/archpsyc.1982.04290040052008","volume":"39","year":"1982","unstructured":"OWENS, DGC, SPONTANEOUS INVOLUNTARY DISORDERS OF MOVEMENT - THEIR PREVALENCE, SEVERITY, AND DISTRIBUTION IN CHRONIC-SCHIZOPHRENICS WITH AND WITHOUT TREATMENT WITH NEUROLEPTICS, ARCHIVES OF GENERAL PSYCHIATRY 39: 452 (1982).","journal-title":"ARCHIVES OF GENERAL PSYCHIATRY"},{"key":"e_1_2_1_36_1","first-page":"647","volume":"1","year":"1973","unstructured":"PAULSON, G.W., ADVANCES IN NEUROLOGY 1: 647 (1973).","journal-title":"ADVANCES IN NEUROLOGY"},{"key":"e_1_2_1_37_1","first-page":"229","volume":"32","year":"1980","unstructured":"SEEMAN, P, BRAIN DOPAMINE-RECEPTORS, PHARMACOLOGICAL REVIEWS 32: 229 (1980).","journal-title":"PHARMACOLOGICAL REVIEWS"},{"key":"e_1_2_1_38_1","first-page":"97","year":"1972","unstructured":"SHADER, R.I., BUTYROPHENONES PSYCH: 97 (1972).","journal-title":"BUTYROPHENONES PSYCH"},{"key":"e_1_2_1_39_1","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1176\/ajp.135.11.1402","volume":"135","year":"1978","unstructured":"SMITH, R.C., DRUG HISTORY AND TARDIVE-DYSKINESIA, AMERICAN JOURNAL OF PSYCHIATRY 135: 1402 (1978).","journal-title":"AMERICAN JOURNAL OF PSYCHIATRY"},{"key":"e_1_2_1_40_1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00433055","volume":"71","year":"1980","unstructured":"STANLEY, M, METOCLOPRAMIDE - ANTIPSYCHOTIC EFFICACY OF A DRUG LACKING POTENCY IN RECEPTOR MODELS, PSYCHOPHARMACOLOGY 71: 219 (1980).","journal-title":"PSYCHOPHARMACOLOGY"},{"key":"e_1_2_1_41_1","first-page":"431","volume":"12","year":"1977","unstructured":"TARSY, D, PATHOPHYSIOLOGIC BASIS OF TARDIVE-DYSKINESIA, BIOLOGICAL PSYCHIATRY 12: 431 (1977).","journal-title":"BIOLOGICAL PSYCHIATRY"},{"key":"e_1_2_1_42_1","first-page":"29","year":"1976","unstructured":"TARSY, D, CLIN NEUROPHARMACOL: 29 (1976).","journal-title":"CLIN NEUROPHARMACOL"},{"key":"e_1_2_1_43_1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1176\/ajp.139.3.329","volume":"139","year":"1982","unstructured":"VARGA, E, PREVALENCE OF SPONTANEOUS ORAL DYSKINESIA IN THE ELDERLY, AMERICAN JOURNAL OF PSYCHIATRY 139: 329 (1982).","journal-title":"AMERICAN JOURNAL OF PSYCHIATRY"},{"key":"e_1_2_1_44_1","first-page":"143","year":"1982","unstructured":"WADDINGTON, J.L., ADV DOPAMINE RES: 143 (1982).","journal-title":"ADV DOPAMINE RES"},{"key":"e_1_2_1_45_1","first-page":"703","volume":"139","year":"1982","unstructured":"WADDINGTON, J.L., TARDIVE-DYSKINESIA, FLUPHENAZINE DECANOATE, AND HALOPERIDOL, AMERICAN JOURNAL OF PSYCHIATRY 139: 703 (1982).","journal-title":"AMERICAN JOURNAL OF PSYCHIATRY"},{"key":"e_1_2_1_46_1","first-page":"367","volume":"68","year":"1980","unstructured":"WADDINGTON, J.L., EUR J PHARM 68: 367 (1980).","journal-title":"EUR J PHARM"},{"key":"e_1_2_1_47_1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0014-2999(80)90177-6","volume":"67","year":"1980","unstructured":"WADDINGTON, J.L., NEUROLEPTIC TREATMENT FOR A SUBSTANTIAL PROPORTION OF ADULT LIFE - BEHAVIORAL SEQUELAE OF 9 MONTHS HALOPERIDOL ADMINISTRATION, EUROPEAN JOURNAL OF PHARMACOLOGY 67: 363 (1980).","journal-title":"EUROPEAN JOURNAL OF PHARMACOLOGY"},{"key":"e_1_2_1_48_1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0014-2999(81)90459-3","volume":"69","year":"1981","unstructured":"WADDINGTON, J.L., SEQUELAE OF 6 MONTHS CONTINUOUS ADMINISTRATION OF CIS(Z)-FLUPENTHIXOL AND TRANS(E)-FLUPENTHIXOL IN THE RAT, EUROPEAN JOURNAL OF PHARMACOLOGY 69: 511 (1981).","journal-title":"EUROPEAN JOURNAL OF PHARMACOLOGY"},{"key":"e_1_2_1_49_1","first-page":"1375","volume":"1","year":"1981","unstructured":"WADDINGTON, J.L., PROLONGED DOPAMINE RECEPTOR BLOCKADE IN RATS AFTER TERMINATION OF LONG-TERM DEPOT FLUPHENAZINE, LANCET 1: 1375 (1981).","journal-title":"LANCET"},{"key":"e_1_2_1_50_1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF00433256","volume":"71","year":"1980","unstructured":"WADDINGTON, J.L., SPONTANEOUS ACTIVITY AND APOMORPHINE STEREOTYPY DURING AND AFTER WITHDRAWAL FROM 3 1\/2 MONTHS CONTINUOUS ADMINISTRATION OF HALOPERIDOL - SOME METHODOLOGICAL ISSUES, PSYCHOPHARMACOLOGY 71: 75 (1980).","journal-title":"PSYCHOPHARMACOLOGY"}],"container-title":["Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/science.6132447","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T16:09:47Z","timestamp":1705248587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/science.6132447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,4,29]]},"references-count":50,"journal-issue":{"issue":"4596","published-print":{"date-parts":[[1983,4,29]]}},"alternative-id":["10.1126\/science.6132447"],"URL":"https:\/\/doi.org\/10.1126\/science.6132447","relation":{},"ISSN":["0036-8075","1095-9203"],"issn-type":[{"value":"0036-8075","type":"print"},{"value":"1095-9203","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983,4,29]]}}}